Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NP2GO vs AgelessRx

NP2GO
Graded #23Editorial

Lower grade

vs+4
AgelessRx
Graded #11Partner

Higher grade

The verdict

AgelessRx takes it — 84/100 to 80/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the lowest compounded-semaglutide pricing, with some brand-name access.

Partner links are labeled — we may earn a commission at no cost to you. It never changes the grade.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgelessRx +9
81
90
Dose & formulationEven
80
80
Clinical oversightAgelessRx +4
79
83
Labs & monitoringAgelessRx +4
78
82
FulfillmentAgelessRx +2
82
84
Contract termsAgelessRx +3
82
85
NP2GO · left barAgelessRx · right bar

The numbers

MetricNP2GOAgelessRx
WeighScore80/10084/100
GradeB−B
Scorecard rank#23#11
Semaglutide$150/mo$139/mo
Tirzepatide$250/moNot disclosed
Coverage40 statesNot disclosed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
RelationshipEditorialPartner
NP2GO

Graded #23 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states
AgelessRx

Graded #11 · B

Strengths

  • Low-end semaglutide pricing
  • Some brand-name access
  • Established brand

Where it loses points

  • Tirzepatide pricing not disclosed
  • States not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 25 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard